Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AKERS Akers Biosciences, Inc., together with its subsidiaries, develops, produces, and sells rapid screening and testing products designed to deliver medical devices to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. Its products include BreathScan, a disposable breath alcohol detector; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol ?Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek that detects aldehydes or oxidative stress in exhaled human breath. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.
I got greedy and I paid for it. Big. I really suck
* * $AKER Video Chart 04-06-2020 * *
Link to Video - click here to watch the technical chart video
any guess to AH?
$AKER Pincher Chart
Congrats bud. what do need to break even...if you don't mind me asking. or it's none of my beeswax.
I've been holding shares for over a year. Suffered thru their R/S and float downs...hope to get my money back. Happy for the new investors...hope you makes gains but sell...sell...sell if you do.
On otc the s o is close to nothing
Short squeeze will bring this to true valuation.
Yes. Way oversold. Looking ready for a pop.
Anything between this range and $3.00 you are golden if you are able to nibble here and there, cause when news hits easy peasy 5-6 dollars in a blink of an eye and depending on the news even 8 dollars.
One news will set this on fire. That is all it needs, just one news.
pauljack well I was wrong on the timing...
hope it works out better for you
I ended up selling for a LOSS
I think that’s going to happen soon
A lil patience will pay off IMO
and only 2m share offering @$4, thats not alot of shares
with patience, I see $4 again within 30days
and if they get a squeeze then 5-8
AKER
* * $AKER Video Chart 12-05-2019 * *
Link to Video - click here to watch the technical chart video
There is no mention of an RS - just an AS increase
Too much of a drop to pass up picking up some shares.
Today's news sequence reminds me why I stopped trading this POS long ago...I almost nibbled, but cooler heads prevailed fortunately...the first news is just Jim Jordan giving Dr. Strauss the assist for the second news...
So , another R/S eh ? I am out ... Buh bye ...
I received an email also from TDA this morning... I haven't had time to look at in depth, yet...
It may be that the difference between the settlement price and what you sold at may be a positive gain for you so ....
It may be worth the time / effort to fill out the forms and send them in . Who knows ?
Correct , only share holders whose trades incurred a loss would be included in the suit .
These suits are filed to try and recover losses only .
Did you buy any AKER stock during the time period listed on the cover sheet ?
Did you suffer any losses from the sale of that stock ?
If so , you're in the suit . If not , throw in trash .
Hope this helps .
I don't own this stock anymore, sold it a couple of years ago, but just got a letter for a class action suit. Anyone know anything about this?
* * $AKER Video Chart 08-13-2019 * *
Link to Video - click here to watch the technical chart video
Very poor entries even if it does pop now, had to fly away to some other board where your errors wouldn't be so obvious. lol
Starting to look int to me love these wedges I’ve made a lot m here before wonder what’s happening lately science wise
I'm loading big time here.AKER huge accumulation .90 s to $1.17 big churning going on here.soon news drop here.BOOOM time will come.our way.
So far nothing, big churning going on that's all I see.news will hit and $2s will come
Double bottom in last month or so.look at charts.something coming.uptrend in place.AKER has a big pipe line.
Still here --Looks ready to fly. Huge volume for AKER and up 30 per cent. Looking for major news next week or should I say hoping for news.
* * $AKER Video Chart 03-07-2019 * *
Link to Video - click here to watch the technical chart video
I'm here still loading.been loading 90 s to $1.05. 141,000 shares.waiting for news.
Anyone alive here?
What yOur rumors about the silence and the company future? Or you goes by chart that you are so sure for the 2zz dollar? I am interested. I watch nearly over a year this stock and I think we can see more than two bucks, patience and balls of steel is necessary. Thanks mojo joyo
Hope you learning how to trade rookie.$2.00s will come.not in a hurry.I'm super loaded.
Followers
|
90
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2221
|
Created
|
01/15/15
|
Type
|
Free
|
Moderators |
Akers Biosciences mission is dedicated to solving global health challenges. Akers was founded in 1989 and has over
30 years of success in the health diagnostic industry having developed proprietary, in vitro diagnostic technologies.
In March of 2020, in an attempt to further their mission, Akers announced a strategic partnership with Premas Biotech.
The partnerships primary objective is to focus on novel vaccine candidates.
The emergence of this pandemic offers an opportunity for the company to be a solution in the healthcare space,
one that sets the stage for our next chapter of growth.
Akers Biosciences Schedules Conference Call to Discuss Licensing Announcement with Premas Biotech for a Coronvirus Vaccine Candidate
Premas develops novel & transformational technologies and partners with global biopharmaceutical companies to build and develop novel biotherapeutic & vaccine candidates.
Akers licensed a novel coronavirus vaccine candidate under development by Premas using Premas’ genetically engineered S. cerevisiae platform, D-Crypt™.
The Premas platform has three key advantages which will set this vaccine candidate apart from industry peers.
Premas successfully cloned three Coronavirus antigens, Spike (S), Envelope (E), and Membrane (M) in the first quarter of 2020 which further differentiates our vaccine candidate.
We aim to provide the immune system with several opportunities to identify the virus; a design concept extremely important for efficacy and our future success.
We held a conference call with Prabuddha Kundu, Co-Founder and Managing Director at Premas Biotech, in late March.
The transcript, which provides additional information on our philosophy and milestone timeline, can be accessed here.
PIFA® technology is a cutting-edge, patented immunoassay method which rapidly, easily, and accurately detects target antigens or antibodies.
PIFA® technology is based on the selective filtration of microparticles in response to antibody/antigen binding.
Dyed microparticles coated with antigens or antibodies determine the visual signal for the results of the assay.
The presence of a corresponding antibody or antigen in the test sample results in the formation of a matrix of microparticles, which are more susceptible to filtration.
The inability of these matrixed microparticles to move through the filter, and the resulting color change in the reagent mixture,
signal positive reactivity of the test sample (e.g. the presence of target antigens or antibodies).
Key features of PIFA® technology make it advantageous for a broad array of uses:
PIFA® technology is currently used in:
Licensing Availability
PIFA® technology is available for licensing. To inquire about licensing or for technical inquiries, please contact us.
Patent Information
Shs Outstand | 8.72M
|
Insider Trans | -0.83%
|
Book/sh | 2.96 |
Cash/sh | 2.00 |
Debt/Eq NO DEBT | 0.00 |
52W Range | 1.55 - 12.72 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |